Serotonin syndrome, characterized by autonomic, neuromuscular, and mental status changes, is an uncommon but well-established risk of psychotropic medications. The presentation can be highly variable, especially when triggered by agents with effects on additional neurotransmitters.1 The presence of a nonspecific prodrome has been reported but poorly characterized and can lead to misattribution of symptoms.2 We describe a case of serotonin syndrome with insidious onset in a boy treated with multiple medications for behavioral dysregulation.
|Original language||English (US)|
|Number of pages||2|
|Journal||Journal of the American Academy of Child and Adolescent Psychiatry|
|State||Published - Feb 2021|
ASJC Scopus subject areas
- Developmental and Educational Psychology
- Psychiatry and Mental health